SG10202102509TA - Micrornas as biomarkers for endometriosis - Google Patents

Micrornas as biomarkers for endometriosis

Info

Publication number
SG10202102509TA
SG10202102509TA SG10202102509TA SG10202102509TA SG10202102509TA SG 10202102509T A SG10202102509T A SG 10202102509TA SG 10202102509T A SG10202102509T A SG 10202102509TA SG 10202102509T A SG10202102509T A SG 10202102509TA SG 10202102509T A SG10202102509T A SG 10202102509TA
Authority
SG
Singapore
Prior art keywords
mir
endometriosis
mirna
subject
mirnas
Prior art date
Application number
SG10202102509TA
Other languages
English (en)
Inventor
Hugh Taylor
Original Assignee
Univ Yale
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Univ Yale filed Critical Univ Yale
Publication of SG10202102509TA publication Critical patent/SG10202102509TA/en

Links

Classifications

    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/68—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids
    • G01N33/689—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids related to pregnancy or the gonads
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/68—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
    • C12Q1/6876—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes
    • C12Q1/6883—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes for diseases caused by alterations of genetic material
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/5308—Immunoassay; Biospecific binding assay; Materials therefor for analytes not provided for elsewhere, e.g. nucleic acids, uric acid, worms, mites
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q2600/00—Oligonucleotides characterized by their use
    • C12Q2600/106—Pharmacogenomics, i.e. genetic variability in individual responses to drugs and drug metabolism
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q2600/00—Oligonucleotides characterized by their use
    • C12Q2600/112—Disease subtyping, staging or classification
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q2600/00—Oligonucleotides characterized by their use
    • C12Q2600/158—Expression markers
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q2600/00—Oligonucleotides characterized by their use
    • C12Q2600/178—Oligonucleotides characterized by their use miRNA, siRNA or ncRNA
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2800/00—Detection or diagnosis of diseases
    • G01N2800/36—Gynecology or obstetrics
    • G01N2800/364—Endometriosis, i.e. non-malignant disorder in which functioning endometrial tissue is present outside the uterine cavity

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Molecular Biology (AREA)
  • Immunology (AREA)
  • Urology & Nephrology (AREA)
  • Hematology (AREA)
  • Biomedical Technology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Analytical Chemistry (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Biochemistry (AREA)
  • Microbiology (AREA)
  • Biotechnology (AREA)
  • Physics & Mathematics (AREA)
  • Pathology (AREA)
  • Medicinal Chemistry (AREA)
  • Wood Science & Technology (AREA)
  • Genetics & Genomics (AREA)
  • Food Science & Technology (AREA)
  • Cell Biology (AREA)
  • General Physics & Mathematics (AREA)
  • Zoology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Reproductive Health (AREA)
  • Biophysics (AREA)
  • Pregnancy & Childbirth (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • General Engineering & Computer Science (AREA)
  • Gynecology & Obstetrics (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Endocrinology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
SG10202102509TA 2016-08-30 2017-08-30 Micrornas as biomarkers for endometriosis SG10202102509TA (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US201662381130P 2016-08-30 2016-08-30

Publications (1)

Publication Number Publication Date
SG10202102509TA true SG10202102509TA (en) 2021-04-29

Family

ID=61301726

Family Applications (2)

Application Number Title Priority Date Filing Date
SG10202102509TA SG10202102509TA (en) 2016-08-30 2017-08-30 Micrornas as biomarkers for endometriosis
SG11201901834WA SG11201901834WA (en) 2016-08-30 2017-08-30 Micrornas as biomarkers for endometriosis

Family Applications After (1)

Application Number Title Priority Date Filing Date
SG11201901834WA SG11201901834WA (en) 2016-08-30 2017-08-30 Micrornas as biomarkers for endometriosis

Country Status (11)

Country Link
US (3) US10982282B2 (cg-RX-API-DMAC7.html)
EP (1) EP3506912B1 (cg-RX-API-DMAC7.html)
JP (2) JP2019528081A (cg-RX-API-DMAC7.html)
KR (1) KR20190057305A (cg-RX-API-DMAC7.html)
CN (1) CN109890394A (cg-RX-API-DMAC7.html)
AU (1) AU2017319325A1 (cg-RX-API-DMAC7.html)
BR (1) BR112019004075A2 (cg-RX-API-DMAC7.html)
CA (1) CA3035429A1 (cg-RX-API-DMAC7.html)
MX (1) MX2019002425A (cg-RX-API-DMAC7.html)
SG (2) SG10202102509TA (cg-RX-API-DMAC7.html)
WO (1) WO2018044979A1 (cg-RX-API-DMAC7.html)

Families Citing this family (20)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US11993816B2 (en) 2014-03-27 2024-05-28 Yale University Circulating microRNA as biomarkers for endometriosis
US10982282B2 (en) 2016-08-30 2021-04-20 Yale University MicroRNAs as biomarkers for endometriosis
JP2020532305A (ja) * 2017-08-30 2020-11-12 ドット ラボラトリーズ, インコーポレイテッド 子宮内膜症を検出および処置するための方法および組成物
EP3820483A4 (en) * 2018-07-13 2023-03-01 Yale University COMPOSITIONS AND METHODS FOR THE TREATMENT OF ENDOMETRIOSIS
KR102089559B1 (ko) * 2018-08-31 2020-03-16 차의과학대학교 산학협력단 난소의 fsh에 대한 반응성의 진단 또는 예측용 바이오마커 및 이의 용도
US11315660B2 (en) 2018-10-31 2022-04-26 Dot Laboratories, Inc. Method of detecting and treating endometriosis in a female subject
US20210404002A1 (en) * 2018-10-31 2021-12-30 Yale University Quantitative Algorithm for Endometriosis
WO2020146544A1 (en) * 2019-01-09 2020-07-16 Research Institute At Nationwide Children's Hospital A novel method for monitoring endometriosis and associated disorders
WO2020179895A1 (ja) 2019-03-07 2020-09-10 東レ株式会社 子宮平滑筋肉腫の検出のためのキット、デバイス及び方法
ES2787725A1 (es) * 2019-04-15 2020-10-16 Univ Granada Metodo de obtencion de datos utiles para diagnosticar telangiectasia hemorragica hereditaria
CN110144394A (zh) * 2019-04-18 2019-08-20 辽宁省肿瘤医院 一种子宫内膜异位症诊断、预后标志物及其应用
EP4004551A1 (en) * 2019-07-22 2022-06-01 F. Hoffmann-La Roche AG Substance p as blood biomarker for the non-invasive diagnosis of endometriosis
JP7421631B2 (ja) * 2019-07-22 2024-01-24 エフ. ホフマン-ラ ロシュ アーゲー 子宮内膜症の非侵襲的診断のための血液バイオマーカーとしてのs100a8
KR20220016210A (ko) * 2019-07-22 2022-02-08 에프. 호프만-라 로슈 아게 자궁내막증의 비-침습적 진단용 혈액 생물표지자로써 s100a9
US11965879B2 (en) 2019-08-23 2024-04-23 Mcmaster University Method for diagnosing and assessing endometriosis
KR102242639B1 (ko) * 2020-01-28 2021-04-21 고려대학교 산학협력단 간 섬유화 진단용 바이오마커 miRNA4668-5p
KR102316507B1 (ko) * 2020-02-28 2021-10-22 차의과학대학교 산학협력단 난소 예비력 바이오마커 및 이의 용도
CN111909997B (zh) 2020-09-09 2021-09-28 上海交通大学 miRNA标志物在制备奥氮平治疗精神分裂症疗效评估方面的产品中的应用及试剂盒
JP7868837B2 (ja) * 2020-10-12 2026-06-02 学校法人近畿大学 ホウ素化合物およびその製造方法
KR102940037B1 (ko) * 2022-12-06 2026-03-16 연세대학교 산학협력단 자궁내막증 진단용 조성물

Family Cites Families (20)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20090317820A1 (en) 2008-05-19 2009-12-24 The Regents Of The University Of California Micro-rna profile in human saliva and its use for detection of oral cancer
EP2350320A4 (en) 2008-11-12 2012-11-14 Caris Life Sciences Luxembourg Holdings METHOD AND SYSTEMS FOR USE OF EXOSOMES FOR THE DETERMINATION OF PHENOTYPES
EP2416789B1 (en) 2009-04-07 2017-06-21 Velin-Pharma A/S Method and device for treatment of conditions associated with inflammation or undesirable activation of the immune system
AU2011223789A1 (en) * 2010-03-01 2012-09-20 Caris Life Sciences Switzerland Holdings Gmbh Biomarkers for theranostics
WO2012103355A2 (en) 2011-01-26 2012-08-02 Cepheid Methods of detecting lung cancer
WO2012112883A1 (en) 2011-02-18 2012-08-23 Yale University The kras-variant and endometriosis
FR2984358A1 (fr) * 2011-12-16 2013-06-21 Genethon Methodes pour le diagnostic de dystrophies musculaires
WO2013148151A1 (en) 2012-03-29 2013-10-03 University Of Pittsburgh - Of The Commonwealth System Of Higher Education Plasma microribonucleic acids as biomarkers for endometriosis and endometriosis-associated ovarian cancer
US10927412B2 (en) 2013-10-01 2021-02-23 The Regents Of The University Of California Endometriosis classifier
CN105917005B (zh) * 2013-11-18 2020-09-11 迪阿米尔有限责任公司 使用来自体液的miRNA检测和监控帕金森病(PD)的方法
GB201403489D0 (en) * 2014-02-27 2014-04-16 Univ London Queen Mary Biomarkers for endometriosis
US9650676B2 (en) 2014-03-19 2017-05-16 University Of South Carolina Leukocyte MicroRNAS for use in diagnosis and treatment of endometriosis
US11993816B2 (en) 2014-03-27 2024-05-28 Yale University Circulating microRNA as biomarkers for endometriosis
EP2924126B1 (en) * 2014-03-28 2018-04-18 Tervisetehnoloogiate Arenduskeskus AS Method for using microRNA (miRNA) for detection of endometriosis
GB201603967D0 (en) * 2016-03-08 2016-04-20 Univ Birmingham Biomarkers of traumatic brain injury
US10982282B2 (en) 2016-08-30 2021-04-20 Yale University MicroRNAs as biomarkers for endometriosis
JP2020532305A (ja) 2017-08-30 2020-11-12 ドット ラボラトリーズ, インコーポレイテッド 子宮内膜症を検出および処置するための方法および組成物
US20210404002A1 (en) 2018-10-31 2021-12-30 Yale University Quantitative Algorithm for Endometriosis
US11315660B2 (en) 2018-10-31 2022-04-26 Dot Laboratories, Inc. Method of detecting and treating endometriosis in a female subject
BR112021021866A2 (pt) 2019-04-29 2021-12-21 Dot Laboraties Inc Classificadores para a detecção de endometriose

Also Published As

Publication number Publication date
CA3035429A1 (en) 2018-03-08
JP2019528081A (ja) 2019-10-10
CN109890394A (zh) 2019-06-14
US12077803B2 (en) 2024-09-03
US11220713B2 (en) 2022-01-11
US20220049312A1 (en) 2022-02-17
KR20190057305A (ko) 2019-05-28
AU2017319325A1 (en) 2019-03-21
EP3506912A1 (en) 2019-07-10
BR112019004075A2 (pt) 2019-05-28
JP2022188086A (ja) 2022-12-20
MX2019002425A (es) 2019-08-16
SG11201901834WA (en) 2019-03-28
EP3506912B1 (en) 2024-04-03
EP3506912A4 (en) 2020-08-19
US20190276893A1 (en) 2019-09-12
WO2018044979A1 (en) 2018-03-08
US10982282B2 (en) 2021-04-20
US20210180134A1 (en) 2021-06-17

Similar Documents

Publication Publication Date Title
GB201403489D0 (en) Biomarkers for endometriosis
ZA201605660B (en) Multispecific antibodies
GB201420908D0 (en) Biomarkers
HUE045330T2 (hu) Légnyomó szivattyú
GB201401603D0 (en) Biomarkers
AU365194S (en) An automobile
EP3122905A4 (en) Circulating micrornas as biomarkers for endometriosis
GB201404189D0 (en) Novel biomarkers
GB201500729D0 (en) Novel Biomarkers
GB201512133D0 (en) Biomarkers
GB201420239D0 (en) Biomarker
GB201416015D0 (en) Biomarker
GB2533850B (en) Rapid inflator
GB201516841D0 (en) Novel biomarker
GB201519704D0 (en) Biomarkers
GB201513683D0 (en) Biomarkers
GB201521446D0 (en) Biomarker
PH32015000925S1 (en) An automobile
GB201514587D0 (en) Motor for turbines improvements
GB201517731D0 (en) Methods for cardiovascular conditions
PH32015001034S1 (en) Automobile
PH32015000189S1 (en) An automobile
GB201501511D0 (en) Biomarker
GB201501480D0 (en) Biomarker
PH32015000939S1 (en) Automobile